Last July, Dr. James H. McKerrow became only the second dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences, which opened its doors to its first class in the fall of 2002. McKerrow is also an alumnus of UC San Diego—he earned his Ph.D. in biology in 1973.
UC San Diego is one of several U.S. and Mexican institutions of higher education to join together and launch the CaliBaja Consortium for Higher Education with the goal of becoming a leader in cross-border education by 2020.
Obesity causes inflammation, which can in turn lead to type 2 diabetes. What isn’t well established is how inflammation causes diabetes — or what we can do to stop it. Researchers at UC San Diego School of Medicine have discovered that the inflammatory molecule LTB4 promotes insulin resistance, a first step in developing type 2 diabetes. What’s more, the team found that genetically removing the cell receptor that responds to LTB4, or blocking it with a drug, improves insulin sensitivity in obese mice.